Market Currents
After meeting with management, Jefferies believes any acquisition offers for Amylin (AMLN -1.1%)...
-
Friday, June 15, 2012, 2:49 PM ETAfter meeting with management, Jefferies believes any acquisition offers for Amylin (AMLN -1.1%) would have to be at least in the low-to-mid $30s to be considered. Jefferies thinks Amylin will feel pressure to make strategic decisions on its independence by September and keeps a Buy rating on the stock with a $32 price target.
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
This news story has 1 comment:
BUt brilliant Icahn would have sold at $22 - thats a 30% loss ... for shareholders